BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 19298592)

  • 1. The imbalance between Survivin and Bim mediates tumour growth and correlates with poor survival in patients with multiple myeloma.
    Romagnoli M; Séveno C; Wuillème-Toumi S; Amiot M; Bataille R; Minvielle S; Barillé-Nion S
    Br J Haematol; 2009 Apr; 145(2):180-9. PubMed ID: 19298592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The imbalance between Bim and Mcl-1 expression controls the survival of human myeloma cells.
    Gomez-Bougie P; Bataille R; Amiot M
    Eur J Immunol; 2004 Nov; 34(11):3156-64. PubMed ID: 15459900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of MDR1 and survivin, and decreased Bim expression mediate multidrug-resistance in multiple myeloma cells.
    Tsubaki M; Satou T; Itoh T; Imano M; Komai M; Nishinobo M; Yamashita M; Yanae M; Yamazoe Y; Nishida S
    Leuk Res; 2012 Oct; 36(10):1315-22. PubMed ID: 22819074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of ERK-BIM and STAT3-survivin signaling pathways in ALK inhibitor-induced apoptosis in EML4-ALK-positive lung cancer.
    Takezawa K; Okamoto I; Nishio K; Jänne PA; Nakagawa K
    Clin Cancer Res; 2011 Apr; 17(8):2140-8. PubMed ID: 21415216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noxa up-regulation and Mcl-1 cleavage are associated to apoptosis induction by bortezomib in multiple myeloma.
    Gomez-Bougie P; Wuillème-Toumi S; Ménoret E; Trichet V; Robillard N; Philippe M; Bataille R; Amiot M
    Cancer Res; 2007 Jun; 67(11):5418-24. PubMed ID: 17545623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-specific adenovirus-mediated PUMA gene transfer using the survivin promoter enhances radiosensitivity of breast cancer cells in vitro and in vivo.
    Wang R; Wang X; Li B; Lin F; Dong K; Gao P; Zhang HZ
    Breast Cancer Res Treat; 2009 Sep; 117(1):45-54. PubMed ID: 18791823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. By inhibiting Src, verapamil and dasatinib overcome multidrug resistance via increased expression of Bim and decreased expressions of MDR1 and survivin in human multidrug-resistant myeloma cells.
    Tsubaki M; Komai M; Itoh T; Imano M; Sakamoto K; Shimaoka H; Takeda T; Ogawa N; Mashimo K; Fujiwara D; Mukai J; Sakaguchi K; Satou T; Nishida S
    Leuk Res; 2014 Jan; 38(1):121-30. PubMed ID: 24239173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of Akt induces significant downregulation of survivin and cytotoxicity in human multiple myeloma cells.
    Hideshima T; Catley L; Raje N; Chauhan D; Podar K; Mitsiades C; Tai YT; Vallet S; Kiziltepe T; Ocio E; Ikeda H; Okawa Y; Hideshima H; Munshi NC; Yasui H; Richardson PG; Anderson KC
    Br J Haematol; 2007 Sep; 138(6):783-91. PubMed ID: 17760810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Melphalan-induced apoptosis in multiple myeloma cells is associated with a cleavage of Mcl-1 and Bim and a decrease in the Mcl-1/Bim complex.
    Gomez-Bougie P; Oliver L; Le Gouill S; Bataille R; Amiot M
    Oncogene; 2005 Dec; 24(54):8076-9. PubMed ID: 16091744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting the miR-221-222/PUMA/BAK/BAX Pathway Abrogates Dexamethasone Resistance in Multiple Myeloma.
    Zhao JJ; Chu ZB; Hu Y; Lin J; Wang Z; Jiang M; Chen M; Wang X; Kang Y; Zhou Y; Ni Chonghaile T; Johncilla ME; Tai YT; Cheng JQ; Letai A; Munshi NC; Anderson KC; Carrasco RD
    Cancer Res; 2015 Oct; 75(20):4384-4397. PubMed ID: 26249174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Polycomb group protein Bmi-1 is essential for the growth of multiple myeloma cells.
    Jagani Z; Wiederschain D; Loo A; He D; Mosher R; Fordjour P; Monahan J; Morrissey M; Yao YM; Lengauer C; Warmuth M; Sellers WR; Dorsch M
    Cancer Res; 2010 Jul; 70(13):5528-38. PubMed ID: 20530672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance.
    Su L; Wang Y; Xiao M; Lin Y; Yu L
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Oct; 110(4):484-91. PubMed ID: 20868995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TGFbeta-mediated apoptosis of Burkitt's lymphoma BL41 cells is associated with the relocation of mitochondrial BimEL.
    Clybouw C; Mchichi BE; Hadji A; Portier A; Auffredou MT; Arnoult D; Leca G; Vazquez A
    Oncogene; 2008 May; 27(24):3446-56. PubMed ID: 18193085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significant impact of survivin on myeloma cell growth.
    Romagnoli M; Trichet V; David C; Clément M; Moreau P; Bataille R; Barillé-Nion S
    Leukemia; 2007 May; 21(5):1070-8. PubMed ID: 17315024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reciprocal protection of Mcl-1 and Bim from ubiquitin-proteasome degradation.
    Wuillème-Toumi S; Trichet V; Gomez-Bougie P; Gratas C; Bataille R; Amiot M
    Biochem Biophys Res Commun; 2007 Oct; 361(4):865-9. PubMed ID: 17681275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. siRNA targeting survivin inhibits growth and induces apoptosis in human renal clear cell carcinoma 786-O cells.
    Zhang Y; Chen ZD; Du CJ; Xu G; Luo W
    Pathol Res Pract; 2009; 205(12):823-7. PubMed ID: 19628339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of survivin reduces cell proliferation and induces apoptosis in human endometrial cancer.
    Ai Z; Yin L; Zhou X; Zhu Y; Zhu D; Yu Y; Feng Y
    Cancer; 2006 Aug; 107(4):746-56. PubMed ID: 16826583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequent loss of expression of the pro-apoptotic protein Bim in renal cell carcinoma: evidence for contribution to apoptosis resistance.
    Zantl N; Weirich G; Zall H; Seiffert BM; Fischer SF; Kirschnek S; Hartmann C; Fritsch RM; Gillissen B; Daniel PT; Häcker G
    Oncogene; 2007 Oct; 26(49):7038-48. PubMed ID: 17486061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptional repression of Bim by a novel YY1-RelA complex is essential for the survival and growth of Multiple Myeloma.
    Potluri V; Noothi SK; Vallabhapurapu SD; Yoon SO; Driscoll JJ; Lawrie CH; Vallabhapurapu S
    PLoS One; 2013; 8(7):e66121. PubMed ID: 23874387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of silencing survivin gene on sensitivity of myeloma cells to adriamycin].
    Li J; Zhao Y; Luo SK; Zhang DB; Huang BH
    Ai Zheng; 2006 Dec; 25(12):1488-92. PubMed ID: 17166372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.